Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.
Press releases published on May 2, 2025

ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference
LEIDEN, Netherlands …

Pacira BioSciences to Present New Data on Clinical Immunogenicity of Intra-Articular PCRX-201 and Its Implications for Dosing Strategy in Knee Osteoarthritis
BRISBANE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced an upcoming podium …

Vaxart to Host First Quarter 2025 Business Update and Financial Results Conference Call on May 13
Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business update and report financial results for the first quarter ended March 31, 2025, …

CareCloud Announces Preferred Stock Dividend Payments
SOMERSET, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, announced today that its Board of …

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
DALLAS, May 02, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the …

electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies
ROCKAWAY, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (“ECOR,” “electroCore,” or the “Company”) (Nasdaq: ECOR), a commercial-stage bioelectronic technology company, announced today the completion of the merger (the “Merger”) with NeuroMetrix, …

TurnOnGreen, Inc. Reports Strong Electric Vehicle Charging Network Growth in 2024
MILPITAS, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- TurnOnGreen, Inc. (OTC:TOGI) (“TurnOnGreen” or the “Company”), a developer and provider of electric vehicle (“EV”) charging solutions and mission-critical power electronics products, today announced …

ALX Oncology to Report First Quarter 2025 Financial Results on May 8, 2025
SOUTH SAN FRANCISCO, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend …

Vislink Reports Fourth Quarter and Full Year 2024 Financial and Operational Results
Mt. Olive, NJ, May 02, 2025 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (OTCQB: VISL), a global technology leader in the capture, delivery, and management of high-quality live video and associated data in the media and …

iBio Reports Fiscal Third Quarter 2025 Financial Results
SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (Nasdaq:IBIO), today reported financial results for the third quarter ended March 31, 2025, and provided a corporate update on its progress. “During the third quarter we were able to broaden our access …

ARS Pharmaceuticals Announces Co-Promotion Agreement with Partner and Global Allergy Leader ALK-Abelló A/S to Expand Reach of neffy® (epinephrine nasal spray) to Additional U.S. Pediatricians
Agreement builds on landmark licensing deal between ARS Pharma and ALK-Abelló A/S, which provided ARS Pharma with $145 million upfront and ALK with commercialization rights to neffy in Canada, United Kingdom, European Union and certain other countries …

Timothy Hay Market to Hit US$ 6.62 Billion by 2031, Exclusive Research by The Insight Partners
US …

SCROOGE Casino Launches Revolutionary VIP Rakeback Program Amid Social Impact Expansion
Alexandria, Indiana, May 02, 2025 (GLOBE NEWSWIRE) -- SCROOGE Casino, a pioneering force in purpose-driven social gaming, announced its comprehensive VIP Rakeback Program today, set to debut in May 2025. This initiative arrives as the company continues to …

IES Holdings Reports Fiscal 2025 Second Quarter Results
HOUSTON, May 02, 2025 (GLOBE NEWSWIRE) -- IES Holdings, Inc. (or “IES” or the “Company”) (NASDAQ: IESC) today announced financial results for the quarter ended March 31, 2025. Second Quarter 2025 Highlights and Recent Developments Revenue of $834 million …

Trumpcoin ($TRUMP) Surged 30% In April As The Buzz Around Cloud Mining Grew; Investors Seeking Daily Profits With ZA Miner
Middlesex, UK, May 02, 2025 (GLOBE NEWSWIRE) -- Donald Trump is turning up the heat in the crypto space, taking his involvement beyond public statements and into direct digital action. His meme coin, $TRUMP, has recently sparked major attention, shooting …

Tourmaline Bio Reports First Quarter 2025 Financial Results and Recent Business Highlights
– Phase 2 TRANQUILITY trial in patients with elevated high-sensitivity C-reactive protein and chronic kidney disease remains on track for topline data readout in the second quarter 2025 – – Tourmaline expects to provide further details on the clinical …

Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV
VAMOS analysis highlights link between EVAF and reduced muscle quality Case series reports success with combination tesamorelin/GLP-1 receptor agonist therapy MONTREAL, May 02, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “ …

Theratechnologies présente à la conférence ACTHIV 2025 de nouvelles données soulignant l’importance de prendre en charge l’excès de graisse viscérale abdominale chez les personnes vivant avec le VIH
L’analyse réalisée dans le cadre de l’étude VAMOS met en évidence le lien entre l’excès de graisse viscérale abdominale et la diminution de la qualité musculaire Selon ce qu’on rapporte dans la série de cas, l’association de la tésamoréline à un agoniste …

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on May 1, …

Cartesian Therapeutics Announces New Employment Inducement Grants
FREDERICK, Md., May 02, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for the treatment of autoimmune diseases, today announced the granting of …